TORVIGEN's Cancer Research Recombinant Proteins collection brings together a curated portfolio of high-purity recombinant, active, and eukaryotic proteins essential for oncology research. Spanning immune checkpoint regulators (PD-L1, CTLA-4, LAG-3, TIM-3, TIGIT), angiogenic factors (VEGF, Angiopoietin, PLGF), oncogenic growth factors (EGF, HGF, FGF2, PDGF, TGF-β), and key cancer biomarkers (AFP, CEA, EpCAM, Chromogranin A), this collection covers the full breadth of tumor biology signaling axes.
Also included are pro- and anti-inflammatory cytokines (IL-2, IL-6, IL-8, IL-10, IL-12, IL-17, IL-18, IL-23, TNF-α, IFN-γ, GM-CSF), EMT markers (E-cadherin, N-cadherin, Vimentin), matrix metalloproteinases (MMP2, MMP7, MMP9, MMP13), and chemokine receptors (CXCR4) — all available across multiple expression systems to support ELISA, functional bioassays, Western blot, and structural studies.
